Stay updated on Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3 from the page.
    Difference
    0.1%
    Check dated 2026-03-18T21:09:33.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3; no visible changes to content or layout.
    Difference
    0.1%
    Check dated 2026-03-11T17:28:53.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and a funding-status notice along with Revision: v3.4.1 were removed. These are maintenance changes and do not affect the study content.
    Difference
    0.4%
    Check dated 2026-02-11T02:24:46.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    A site-wide notice about government funding and operating status was added, and the page version updated from v3.4.0 to v3.4.1. There are no changes to the study details, outcomes, or core content presented on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T01:21:36.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    A glossary toggle ('Show glossary') was added and the update-label capitalization adjusted. The footer now shows 'Revision: v3.4.0' replacing 'v3.3.4'.
    Difference
    0.2%
    Check dated 2026-01-27T22:56:32.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    The page shows a minor revision update from v3.3.3 to v3.3.4; this does not affect the study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:49:03.000Z thumbnail image

Stay in the know with updates to Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial page.